David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 42,445 shares at $13.49 ($572K) on 2022-05-26, disclosed to the SEC on 2022-05-31.
Open-market purchase of $572k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.49 | 667 | $9K | 1.6% |
| 2 | $13.49 | 19,534 | $264K | 46.0% |
| 3 | $13.49 | 19,534 | $264K | 46.0% |
| 4 | $13.45 | 89 | $1K | 0.2% |
| 5 | $13.45 | 2,621 | $35K | 6.2% |
| Total | $13.49 avg | 42,445 |
| $572K |
| 100% |
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |